Hypereosinophilic syndrome in Hodgkin's disease with increased granulocyte-macrophage colony-stimulating factor

被引:4
作者
Endo, M [1 ]
Usuki, K [1 ]
Kitazume, K [1 ]
Iwabe, K [1 ]
Okuyama, Y [1 ]
Urabe, A [1 ]
机构
[1] KANTO TEISHIN HOSP,DIV HEMATOL,SHINAGAWA KU,TOKYO 141,JAPAN
关键词
Hodgkin's; IL-5; GM-CSF; eosinophilia;
D O I
10.1007/s002770050125
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report a patient with eosinophilia accompanied by Hodgkin's disease who showed remarkable increase in granulocyte-macrophage colony-stimulating factor (GM-CSF) in plasma but no increase in interleukin-5 (IL-5). The plasma GM-CSF level normalized as eosinophilia and lymphadenopathy disappeared after chemotherapy. Immunohistochemical study with immunoperoxidase staining technique showed a positive stain in lymph node cells by monoclonal anti-GM-CSF antibody. Eosinophilia is often accompanied by Hodgkin's disease, and several cases have been reported to show high levels of plasma IL-5. To our knowledge, this is the first report to show a high level of plasma GMCSF in Hodgkin's disease with eosinophilia.
引用
收藏
页码:313 / 314
页数:2
相关论文
共 50 条
[31]   Granulocyte-macrophage colony-stimulating factor promotes human blastocyst development in vitro [J].
Sjöblom, C ;
Wikland, M ;
Robertson, SA .
HUMAN REPRODUCTION, 1999, 14 (12) :3069-3076
[32]   REGULATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND INTERLEUKIN-3 EXPRESSION [J].
NIMER, SD ;
UCHIDA, H .
STEM CELLS, 1995, 13 (04) :324-335
[33]   Compartmentalization of eosinophil granulocyte-macrophage colony-stimulating factor expression in patients with asthma [J].
Sullivan, S ;
Broide, DH .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (04) :966-976
[34]   Granulocyte-Macrophage Colony-Stimulating Factor Is Neuroprotective in Experimental Traumatic Brain Injury [J].
Shultz, Sandy R. ;
Tan, Xin L. ;
Wright, David K. ;
Liu, Shijie J. ;
Semple, Bridgette D. ;
Johnston, Leigh ;
Jones, Nigel C. ;
Cook, Andrew D. ;
Hamilton, John A. ;
O'Brien, Terence J. .
JOURNAL OF NEUROTRAUMA, 2014, 31 (10) :976-983
[35]   FUTURE USES OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) [J].
JONES, TC .
STEM CELLS, 1994, 12 :229-240
[36]   Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain [J].
Cook, Andrew D. ;
Pobjoy, Jarrad ;
Sarros, Shannon ;
Steidl, Stefan ;
Duerr, Manuela ;
Lacey, Derek C. ;
Hamilton, John A. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (02) :265-270
[37]   POTENTIAL USES OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN CHILDREN [J].
FURMAN, WL ;
CRIST, WM .
AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1991, 13 (04) :388-399
[38]   PEGylated murine Granulocyte-macrophage colony-stimulating factor: Production, purification, and characterization [J].
Sainathan, SK ;
Tu, LW ;
Bishnupuri, KS ;
Han, M ;
Li, AG ;
Newberry, RD ;
McDonald, KG ;
Crimmins, DL ;
Houchen, C ;
Anant, S ;
Dieckgraefe, BK .
PROTEIN EXPRESSION AND PURIFICATION, 2005, 44 (02) :94-103
[39]   A Promising Target in Rheumatoid Arthritis Treatment: Granulocyte-Macrophage Colony-Stimulating Factor [J].
A. Berkant Avci ;
Eugen Feist ;
Gerd-R. Burmester .
Current Treatment Options in Rheumatology, 2015, 1 (4) :320-333
[40]   Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19 [J].
Mu, Xiuying ;
Liu, Kai ;
Li, Huajie ;
Wang, Fu-Sheng ;
Xu, Ruonan .
CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (08) :2057-2058